Newsroom
Sorted by: Latest
-
Wildix Redefines Revenue Operations With the Launch of Revenue Intelligence
TALLINN, Estonia--(BUSINESS WIRE)--Wildix, a global leader in AI-powered business solutions, today announced the launch of Revenue Intelligence. This major update transforms how sales leaders monitor, analyse and optimise their revenue engines by integrating advanced agentic AI directly into the communication workflow. Most sales teams generate thousands of calls and chats every month, and lose the intelligence buried inside them. Revenue Intelligence provides a single source of truth for the e...
-
Nombre d’actions et droits de vote composant le capital social de Claranova SE au 31 mars 2026
PARIS--(BUSINESS WIRE)--Regulatory News : Conformément aux articles L.233-8 II du Code de commerce et 223-16 du Règlement général de l’Autorité des Marchés Financiers, Claranova SE (ISIN FR0013426004) (Paris:ALCLA) publie le nombre d’actions composant son capital social ainsi que le nombre de droits de vote associés au 31 mars 2026 : Actions composant le capital 57 206 910 Droits de vote théoriques (A) 57 206 910 Actions privées de droits de vote Autodétention au nominatif (B) 22 973 Autodé...
-
JEDEC® Announces May 2026 Forums Focused on Next-Generation Memory for AI, Server, Cloud, and Mobile Computing
ARLINGTON, Va.--(BUSINESS WIRE)--JEDEC Solid State Technology Association, the global leader in the development of standards for the microelectronics industry, today announced that it is hosting a Mobile/Client/Edge Forum on Tuesday, May 12 and a Server/Cloud Computing/AI Forum on Wednesday, May 13 in San Jose, CA. Advance registration is required and space is limited. For more information and registration, visit the JEDEC website. The Forums offer an impressive lineup of influential speakers c...
-
AM Best Executive Vice President and Chief Strategy Officer to Join Innovation-Focused Panel at Formation ’26
OLDWICK, N.J.--(BUSINESS WIRE)--AM Best Executive Vice President and Chief Strategy Officer Andrea Keenan will join a panel discussion on insurance industry innovation at the Formation ’26 conference, which will be held April 27-29, 2026, in Orlando, FL. The panel discussion, titled, “The Innovation Scorecard: What Analysts Really Look for in Modern Insurers,” will focus on where innovation strategy, measurable outcomes and market perception intersect and the implications for insurers. Since 20...
-
IQM und Real Asset Acquisition Corp. geben die vertrauliche Einreichung eines Entwurfs der Registrierungserklärung auf Formular F-4 im Zusammenhang mit dem geplanten Unternehmenszusammenschluss bekannt
PRINCETON, New Jersey & ESPOO, Finnland--(BUSINESS WIRE)--IQM Finland Oy, ein weltweit führender Anbieter von vor Ort eingesetzten Full-Stack-Supraleiter-Quantencomputern („IQM“, „IQM Quantum Computers“ oder das „Unternehmen“), und Real Asset Acquisition Corp., eine Zweckgesellschaft (Nasdaq: RAAQ) („RAAQ“), gaben heute die vertrauliche Einreichung des Entwurfs der Registrierungserklärung auf Formular F-4 (die „Registrierungserklärung“) bekannt, die von IQM bei der US-Börsenaufsichtsbehörde („S...
-
P&G Enters New Era in Sports as Official Partner of the WNBA
CINCINNATI--(BUSINESS WIRE)--Procter & Gamble and the Women’s National Basketball Association (WNBA) today announced a multi-year, multi-brand partnership, marking a bold new chapter in how P&G and its brands show up across sports and culture. The partnership creates a platform for P&G brands to engage with professional women’s basketball at a defining moment – as the game, its athletes, fans, and influence are reaching new heights. Building on the success of P&G brand Mielle’s...
-
GenSight Biologics publie sa situation de trésorerie et les revenus du programme d’Autorisation d’Accès Compassionnel (AAC) au 31 mars 2026
PARIS--(BUSINESS WIRE)--Regulatory News: GenSight Biologics (Euronext : SIGHT, ISIN : FR0013183985, éligible PEA-PME), société biopharmaceutique dédiée au développement et à la commercialisation de thérapies géniques innovantes pour les maladies neurodégénératives de la rétine et du système nerveux central, publie aujourd’hui sa situation de trésorerie et les revenus de son programme d’Autorisation d’Accès Compassionnel (AAC) au 31 mars 2026. Situation de trésorerie au 31 mars 2026 La trésoreri...
-
GenSight Biologics Reports Cash Position and Revenue from Early Access Program as of March 31, 2026
PARIS--(BUSINESS WIRE)--Regulatory News: GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene therapies for retinal neurodegenerative diseases and central nervous system disorders, today reported its cash position and the revenues from its Named Patient Early Access Program as of March 31, 2026. Cash position as of March 31, 2026 GenSight Biologics’ cash and cash equivalents totaled €3.2 million...
-
M6 METROPOLE TELEVISION : MODALITÉS DE MISE À DISPOSITION DES DOCUMENTS PRÉPARATOIRES À L’ASSEMBLÉE GÉNÉRALE MIXTE DU 28 AVRIL 2026
NEUILLY-SUR-SEINE, France--(BUSINESS WIRE)--Regulatory News: M6 Metropole Television (Paris:MMT): Les actionnaires de Métropole Télévision SA (la « Société ») sont invités à participer à l’Assemblée Générale Mixte qui se tiendra le mardi 28 avril 2026 à 9h00 au Théâtre des Sablons, 70 avenue du Roule, 92200 Neuilly-sur-Seine. L’avis préalable de convocation à l’Assemblée générale comportant l’ordre du jour et les projets de résolutions a été publié au Bulletin des Annonces Légales et Obligatoir...
-
M6 Metropole Television: Procedure for Obtaining Preparatory Documents of the Combined Shareholders’ Meeting to Be Held on April 28, 2026
NEUILLY-SUR-SEINE, France--(BUSINESS WIRE)--Regulatory News: M6 Metropole Television (Paris:MMT): The Shareholders of the company are invited to attend the Combined General Meeting to be held on 28 April 2026, at 9:00 am, at the Théâtre des Sablons, 70 avenue du Roule, 92200 Neuilly-sur-Seine. The preliminary notice of meeting, including the agenda and the presentation of the proposed resolutions, was published in the French “Bulletin des Annonces Légales et Obligatoires (BALO)” n°35 dated Marc...